Trial Profile
A Real-world study evaluating treatment discontinuation and resource utilization associated with fingolimod and dimethyl fumarate in patients with multiple sclerosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Nov 2016
Price :
$35
*
At a glance
- Drugs Dimethyl fumarate (Primary) ; Fingolimod (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions; Therapeutic Use
- 17 Nov 2016 New trial record